Can 18F-FDG PET/CT SUVmax values predict breast and axillary pathological complete response before neoadjuvant chemotherapy in breast cancer?
Introduction Breast cancer is the most common type of cancer in women. Neoadjuvant chemotherapy (NAC) has become the initial treatment for locally advanced breast cancer.1 Its use has expanded after the recommendation for using NAC to T1c-N0 patients with human epidermal growth factor receptor 2 (HER2) positive and triple negative in the 2023 NCCN guideline. […]
Authors
- Ali İhsan Sağlam (ORCID: https://orcid.org/0000-0003-3031-7028)
- Uğur Özsoy (ORCID: https://orcid.org/0000-0001-8937-4348)
- Murat Yıldırım (ORCID: https://orcid.org/0000-0003-2682-8570)
- Bülent Koca (ORCID: https://orcid.org/0000-0001-7614-122X)
Publication Details
- Journal
- Cirugía y Cirujanos (English Edition)
- Published
- 2026-10-30
- DOI
- https://doi.org/10.24875/cirue.m24000969
- Primary Topic
- Medical Imaging Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00